This is filed to conservatively report thrombus.It was reported this was a mitraclip procedure to treat grade 4 functional mitral regurgitation (mr).When attempting the transseptal puncture, prior to inserting the steerable guide catheter (sgc), thrombus was observed on the transseptal needle.The transseptal puncture was successful, the sgc was inserted and thrombus was aspirated over the sgc.Thereafter, the sgc was removed and flushed with saline and the sgc and mitraclip delivery system were inserted, and st-elevation was observed.Heparin was given and the st-elevation disappeared.The mitraclip procedure was continued, one clip was implanted, reducing mr to <1.It is unknown if the mitraclip devices caused or contributed to the thrombus and st elevation.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.The reported patient effects of cardiac enzyme elevation and thrombosis as listed in the mitraclip g4 system instructions for use (ifu), are known possible complications associated with mitraclip procedures.Based on this information, a cause for the reported thrombus could not be determined.The reported cardiac enzyme elevation was a result of the reported thrombus.The reported unexpected medical intervention and medication required were a result of case specific circumstances as the thrombus had to be aspirated and heparin was administered.There is no indication of a product issue with respect to manufacture, design or labeling.
|